Search

Displaying results 6601 - 6610 of 10000 in total
  1. Drug

    Glyceryl Trioleate

    go.drugbank.com/drugs/DB13038
    Investigational

    Glyceryl Trioleate has been investigated for the treatment of Adrenoleukodystrophy.

  2. Drug

    Surinabant

    go.drugbank.com/drugs/DB13070
    Investigational

    Surinabant has been investigated for the treatment of Smoking Cessation.

  3. Drug

    Gisadenafil

    go.drugbank.com/drugs/DB11902
    Investigational

    Gisadenafil has been investigated for the treatment of Prostatic Hyperplasia.

  4. Drug

    Napabucasin

    go.drugbank.com/drugs/DB12155
    Investigational

    Napabucasin has been investigated for the treatment of Colorectal Carcinoma.

  5. Drug

    Cerlapirdine

    go.drugbank.com/drugs/DB12229
    Investigational

    Cerlapirdine has been investigated for the treatment of Alzheimer Disease.

  6. Drug

    Puerarin

    go.drugbank.com/drugs/DB12290
    Investigational

    Puerarin has been investigated for the treatment of Alcohol Abuse.

  7. Drug

    Piclozotan

    go.drugbank.com/drugs/DB12361
    Investigational

    Piclozotan has been investigated for the treatment of Parkinson's Disease.

  8. Drug

    Glyceryl Trierucate

    go.drugbank.com/drugs/DB12528
    Investigational

    Glyceryl Trierucate has been investigated for the treatment of Adrenoleukodystrophy.

  9. Drug

    IGN311

    go.drugbank.com/drugs/DB04988
    Experimental

    IGN311 is a humanized monoclonal antibody (mab) against the Lewis Y carbohydrate antigen, a blood-group-related oligosaccharide.

  10. Drug

    Pamufetinib

    go.drugbank.com/drugs/DB20752
    Investigational

    Pamufetinib has a monoisotopic molecular weight of 518.14 Da. … The usage of the INN stem '-tinib' in the name indicates that Pamufetinib is a tyrosine kinase inhibitor. Pamufetinib is under investigation in clinical trial NCT04999761 (AB122 Platform Study).